封面
市場調查報告書
商品編碼
1344320

肺功能監測設備市場:按產品類型、最終用戶劃分:2023-2032 年全球機會分析與產業預測

Lung Monitoring Devices Market By Product Type (Spirometers, Pulse Oximeters, Capnographs, Others), By End User (Hospitals, Homecare, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日期: | 出版商: Allied Market Research | 英文 224 Pages | 商品交期: 2-3個工作天內

價格

根據Allied Market Research發布的研究報告,肺功能監測設備市場規模將在2022年達到33億美元,2023年至2032年複合年增長率為6.6%,預計2032年將達到61億美元。

肺部監測設備市場-IMG1

肺功能監測設備用於準確、有效率地監測慢性阻塞性肺病(COPD)、囊性纖維化和移植後患者等呼吸系統疾病患者的肺功能。 這些設備可以幫助控制症狀並減少氣喘和慢性阻塞性肺病等多種肺部疾病的惡化。

肺功能監測設備市場的成長是由呼吸系統疾病盛行率的急劇上升、醫療治療的可用性和負擔能力的提高以及先進產品的推出數量的增加所推動的。 例如,2021年3月,領先的製藥公司Vyaire Medical宣佈在歐洲、中東和澳洲的超過15個國家推出其AioCare(HealthUp SA,波蘭)行動肺活量測定係統。 肺活量測定是最常見的肺功能或呼吸測試。

此外,領先的醫療技術公司越來越注重收購提供肺功能監測設備解決方案的公司,預計這將對市場成長做出重大貢獻。 全球肺功能監測設備市場的領先公司正在投資於產品發布、收購、研究和開發,以促進肺功能監測設備的進步等,以加強其市場地位並保持競爭力。我們採用多種策略。

此外,慢性阻塞性肺病盛行率的驚人增長、肺功能監測設備的技術進步以及事故和創傷數量的增加是推動市場成長的一些主要因素。 此外,大城市空氣污染水平的上升以及與吸煙相關的生活方式的改變在很大程度上導致了肺部疾病盛行率的上升。 然而,肺功能監測設備替代療法的可用性以及對肺部疾病認識的缺乏阻礙了市場的成長。 相反,肺功能監測設備在老年人群中的越來越多的應用預計將在不久的將來為市場成長提供利潤豐厚的機會。 此外,肺功能監測設備領域的廣泛研發活動以及醫療基礎設施的顯著改善預計將為預測期內的市場擴張開闢新的途徑。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概述

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 老年人口增加
      • 呼吸系統疾病增加
      • 科技進步迅速
    • 抑制因素
      • 缺乏對呼吸道疾病的認識
    • 機會
      • 越來越偏好家庭醫療護理
  • 新冠肺炎 (COVID-19):市場影響分析

第 4 章肺功能監測設備市場:依產品類型

  • 摘要
  • 肺活量計
  • 脈搏血氧計
  • 二氧化碳描記器
  • 其他

第 5 章肺功能監測設備市場:依最終使用者劃分

  • 摘要
  • 醫院
  • 家庭醫療護理
  • 其他

第6章肺功能監測設備市場:依地區

  • 摘要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他拉丁美洲/中東/非洲

第7章競爭態勢

  • 簡介
  • 關鍵成功策略
  • 10家主要公司的產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022 年主要公司的定位

第8章公司簡介

  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • ResMed Inc.
  • ICU Medical Inc.
  • Vyaire Medical, Inc.
  • Becton, Dickinson and Company
  • Teleflex Incorporated.
  • Baxter International Inc.
Product Code: A12055

According to a new report published by Allied Market Research, titled, "Lung Monitoring Devices Market," The lung monitoring devices market was valued at $3.3 billion in 2022, and is estimated to reach $6.1 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.

Lung Monitoring Devices Market - IMG1

Lung monitoring devices are used for precise and efficient monitoring of lung function for respiratory conditions, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and post-transplant patients. These devices aid in managing symptoms and help reduce exacerbations of multiple lung disorders such as asthma and COPD.

The growth of the lung monitoring devices market is driven by surge in incidence of respiratory diseases, increase in availability & affordability of healthcare treatment, and rise in number of advanced product launches. For instance, in March 2021, Vyaire Medical, a leading pharmaceutical company, announced the launch of the AioCare (HealthUp SA, Poland) mobile spirometry system in more than 15 countries across Europe, the Middle East, and Australia. Spirometry is the most common type of pulmonary function or breathing test.

Moreover, large medical technology firms are increasingly focusing on acquiring companies that provide solutions for lung monitoring devices, which is expected to notably contribute toward the market growth. Prominent players in the global lung monitoring devices market have adopted various strategies such as product launches, acquisition, and investments in R&D for advancement in lung monitoring devices to strengthen their position in the market and sustain the competitive environment.

Moreover, alarming increase in prevalence of COPD, technological advancements in lung monitoring devices, and rise in the number of accidents and trauma are some of the key factors driving the growth of the market. Furthermore, rise in levels of air pollution in metropolitan cities and changes in lifestyles involving cigarette smoking notably contribute toward the growing prevalence of pulmonary diseases. However, availability of alternative treatments for lung monitoring devices and lack of awareness regarding lung diseases hamper the market growth. Conversely, increased application of lung monitoring devices among the geriatric population is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of lung monitoring devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.

The global lung monitoring devices market is segmented into product type, end user, and region. On the basis of product type, the market is classified spirometers, pulse oximeters, capnographs, and others. The spirometers segment further bifurcated into hand-held and table-top. The pulse oximeter segment further classified into bedside pulse oximeter, fingertip pulse oximeter, hand held pulse oximeter, wrist worn pulse oximeter and pediatric pulse oximeter.

Depending on end user, it is classified into hospitals, homecare, and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include: GE Healthcare, Hill-Rom, Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Resmed Inc., Smiths Medical, Vitalograph Ltd., and Vyaire Medical.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the lung monitoring devices market analysis from 2022 to 2032 to identify the prevailing lung monitoring devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the lung monitoring devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global lung monitoring devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End User

  • Hospitals
  • Homecare
  • Others

By Product Type

  • Pulse Oximeters
    • Type
    • Bedside Pulse Oximeter
    • Fingertip Pulse Oximeter
    • Hand held Pulse Oximeter
    • Wrist worn Pulse Oximeter
    • Pediatric Pulse Oximeter
  • Capnographs
  • Others
  • Spirometers
    • Type
    • Hand-Held
    • Table-Top

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Baxter International Inc.
    • Becton, Dickinson and Company
    • ICU Medical Inc.
    • Koninklijke Philips N.V.
    • Masimo Corporation
    • Medtronic plc
    • Nihon Kohden Corporation
    • ResMed Inc.
    • Teleflex Incorporated.
    • Vyaire Medical, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Upsurge in geriatric population
      • 3.4.1.2. Rise in incidence of respiratory diseases
      • 3.4.1.3. Rapid technological advancements
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of awareness regarding respiratory diseases
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in preference for home healthcare
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Spirometers
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Spirometers Lung Monitoring Devices Market by Type
  • 4.3. Pulse Oximeters
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Pulse Oximeters Lung Monitoring Devices Market by Type
  • 4.4. Capnographs
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: LUNG MONITORING DEVICES MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Homecare
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: LUNG MONITORING DEVICES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Product Type
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Product Type
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Product Type
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Product Type
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Product Type
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Product Type
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Product Type
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Product Type
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Product Type
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Product Type
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Product Type
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Product Type
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Product Type
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Product Type
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Product Type
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Product Type
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Product Type
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Product Type
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Product Type
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Product Type
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Product Type
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Product Type
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Product Type
      • 6.5.4.4.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
  • 8.2. Masimo Corporation
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Medtronic plc
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. Nihon Kohden Corporation
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
  • 8.5. ResMed Inc.
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
  • 8.6. ICU Medical Inc.
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
  • 8.7. Vyaire Medical, Inc.
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
  • 8.8. Becton, Dickinson and Company
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
  • 8.9. Teleflex Incorporated.
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
  • 8.10. Baxter International Inc.
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 02. LUNG MONITORING DEVICES MARKET FOR SPIROMETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL SPIROMETERS LUNG MONITORING DEVICES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 04. LUNG MONITORING DEVICES MARKET FOR PULSE OXIMETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL PULSE OXIMETERS LUNG MONITORING DEVICES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 06. LUNG MONITORING DEVICES MARKET FOR CAPNOGRAPHS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. LUNG MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 09. LUNG MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. LUNG MONITORING DEVICES MARKET FOR HOMECARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. LUNG MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. LUNG MONITORING DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA LUNG MONITORING DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 16. U.S. LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. U.S. LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. CANADA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. CANADA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE LUNG MONITORING DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. FRANCE LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. FRANCE LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. UK LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. UK LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. ITALY LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. ITALY LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. SPAIN LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. SPAIN LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC LUNG MONITORING DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 40. CHINA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. CHINA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. JAPAN LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. INDIA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. INDIA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. REST OF ASIA-PACIFIC LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. REST OF ASIA-PACIFIC LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. LAMEA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. LAMEA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. LAMEA LUNG MONITORING DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 55. BRAZIL LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. BRAZIL LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. SAUDI ARABIA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. SAUDI ARABIA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. SOUTH AFRICA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. SOUTH AFRICA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. REST OF LAMEA LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. REST OF LAMEA LUNG MONITORING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 64. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 65. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
  • TABLE 66. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 67. MASIMO CORPORATION: KEY EXECUTIVES
  • TABLE 68. MASIMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 69. MASIMO CORPORATION: PRODUCT SEGMENTS
  • TABLE 70. MASIMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 71. MASIMO CORPORATION: KEY STRATERGIES
  • TABLE 72. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 73. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 74. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 75. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 76. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 77. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
  • TABLE 78. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • TABLE 79. NIHON KOHDEN CORPORATION: PRODUCT SEGMENTS
  • TABLE 80. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
  • TABLE 81. RESMED INC.: KEY EXECUTIVES
  • TABLE 82. RESMED INC.: COMPANY SNAPSHOT
  • TABLE 83. RESMED INC.: PRODUCT SEGMENTS
  • TABLE 84. RESMED INC.: PRODUCT PORTFOLIO
  • TABLE 85. ICU MEDICAL INC.: KEY EXECUTIVES
  • TABLE 86. ICU MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 87. ICU MEDICAL INC.: PRODUCT SEGMENTS
  • TABLE 88. ICU MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 89. VYAIRE MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 90. VYAIRE MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 91. VYAIRE MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 92. VYAIRE MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 93. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 94. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 95. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 96. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 97. TELEFLEX INCORPORATED.: KEY EXECUTIVES
  • TABLE 98. TELEFLEX INCORPORATED.: COMPANY SNAPSHOT
  • TABLE 99. TELEFLEX INCORPORATED.: PRODUCT SEGMENTS
  • TABLE 100. TELEFLEX INCORPORATED.: PRODUCT PORTFOLIO
  • TABLE 101. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 102. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 103. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
  • TABLE 104. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. LUNG MONITORING DEVICES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF LUNG MONITORING DEVICES MARKET, 2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN LUNG MONITORING DEVICES MARKET (2023-2032)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE INTENSITY OF RIVALRY
  • FIGURE 08. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALLUNG MONITORING DEVICES MARKET
  • FIGURE 09. LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2022(%)
  • FIGURE 10. COMPARATIVE SHARE ANALYSIS OF LUNG MONITORING DEVICES MARKET FOR SPIROMETERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF LUNG MONITORING DEVICES MARKET FOR PULSE OXIMETERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LUNG MONITORING DEVICES MARKET FOR CAPNOGRAPHS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LUNG MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. LUNG MONITORING DEVICES MARKET, BY END USER, 2022(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LUNG MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LUNG MONITORING DEVICES MARKET FOR HOMECARE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LUNG MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. LUNG MONITORING DEVICES MARKET BY REGION, 2022
  • FIGURE 19. U.S. LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 20. CANADA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 21. MEXICO LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. GERMANY LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. FRANCE LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. UK LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. ITALY LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. SPAIN LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. REST OF EUROPE LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. CHINA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. JAPAN LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. INDIA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. AUSTRALIA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SOUTH KOREA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. REST OF ASIA-PACIFIC LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. BRAZIL LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. SAUDI ARABIA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SOUTH AFRICA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF LAMEA LUNG MONITORING DEVICES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 41. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 42. COMPETITIVE DASHBOARD
  • FIGURE 43. COMPETITIVE HEATMAP: LUNG MONITORING DEVICES MARKET
  • FIGURE 44. TOP PLAYER POSITIONING, 2022
  • FIGURE 45. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 47. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 48. MASIMO CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 49. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 51. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 52. NIHON KOHDEN CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. NIHON KOHDEN CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. NIHON KOHDEN CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. RESMED INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 56. RESMED INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. RESMED INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. ICU MEDICAL INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. ICU MEDICAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. ICU MEDICAL INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. TELEFLEX INCORPORATED.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. TELEFLEX INCORPORATED.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. TELEFLEX INCORPORATED.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 67. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 69. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)